A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis

Psoriatic Plaque Clinical Trial

Official title:
A Multicenter, Double-Blind, Randomized, Vehicle-Controlled Phase 1/2a Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 Gel in Subjects With Plaque Psoriasis

Status Completed

Clinical Trial Summary

This is a multicenter, double-blind, randomized, vehicle-controlled, parallel-group proof-of-concept study designed to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of topically applied ESR-114 following twice daily (BID) application for 42 days (6 weeks).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03630939
Study type	Interventional
Source	Escalier Biosciences B.V.
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	August 9, 2018
Completion date	June 12, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05144165` - Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
Active, not recruiting	`NCT04911751` - A Study to Investigate Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type Psoriasis	Phase 2
Recruiting	`NCT02999776` - Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis	Phase 1
Recruiting	`NCT04099979` - A Pilot Study to Explore the Role of Gut Flora in Psoriasis
Completed	`NCT03726489` - Light Treatment Effectiveness (LITE) Study	N/A